{"id":"NCT03912259","sponsor":"Sanofi","briefTitle":"Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis","officialTitle":"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Chinese Adult Patients With Moderate-to-severe Atopic Dermatitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-12-19","primaryCompletion":"2020-02-14","completion":"2020-02-14","firstPosted":"2019-04-11","resultsPosted":"2021-04-05","lastUpdate":"2023-12-19"},"enrollment":165,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Atopic Dermatitis"],"interventions":[{"type":"DRUG","name":"Dupilumab","otherNames":["Dupixent","SAR231893"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Emollient (moisturizer)","otherNames":[]}],"arms":[{"label":"Placebo Q2W","type":"PLACEBO_COMPARATOR"},{"label":"Dupilumab 300 mg Q2W","type":"EXPERIMENTAL"}],"summary":"Primary Objective:\n\nTo evaluate the efficacy of dupilumab monotherapy compared to placebo treatment in adult participants with moderate-to-severe atopic dermatitis (AD).\n\nSecondary Objectives:\n\n* To evaluate the safety of dupilumab monotherapy compared to placebo treatment in adult participants with moderate-to-severe AD.\n* To evaluate the effect of dupilumab on improving patient reported outcomes (PROs).\n* To evaluate dupilumab immunogenicity.","primaryOutcome":{"measure":"Number of Participants With Investigator's Global Assessment (IGA) Score of \"0\" or \"1\" and Reduction From Baseline of Greater Than or Equal to (>=) 2 Points at Week 16","timeFrame":"Baseline, Week 16","effectByArm":[{"arm":"Placebo Q2W","deltaMin":4,"sd":null},{"arm":"Dupilumab 300 mg Q2W","deltaMin":22,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":10},"locations":{"siteCount":27,"countries":["China"]},"refs":{"pmids":["36525340"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":83},"commonTop":["Dermatitis Atopic","Upper Respiratory Tract Infection","Protein Urine Present","Conjunctivitis","Conjunctivitis Allergic"]}}